Amira S A Said

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 17

Top Topics

Rheumatoid Arthritis

Coronavirus Disease

Gold Nanoparticles

Disease Activity

Top Venues

Healthcare (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, Roquyya Gul, Muhammad Irfan, Muhammad Naveed, Munir Ahmad Bhinder, Muhammad Usman Ghani, Nadia Hussain, Amira S A Said, Amal H I Al Haddad, Mahjabeen Saleem
Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches. Vaccines 11 (1) (2023)
Moustafa Aldaly, Azza Hussien, Inas Mohsen El-Nadi, Nabila Ibrahim Laz, Amira S A Said, Mohammad M AlAhmad, Raghda R S Hussein, Al Shaimaa Ibrahim Rabie, Ahmed Hassan Shaaban
A Comparison of 3D Conformal and Deep Inspiratory Breath Holding vs. 4D-CT Intensity-Modulated Radiation Therapy for Patients with Left Breast Cancer. Cancers 15 (24) (2023)
Al Shaimaa Ibrahim Rabie, Hager Salah, Amira S A Said, Ahmed Hassan Shaaban, Lamya Mohamed Abdou, Doaa Mahmoud Khalil, Zelal Kharaba, Hala Afifi, Mahmoud R Sofy, Eman M I Youssef, Eman S M Bayoumy, Raghda R S Hussein
Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection. Healthcare (Basel, Switzerland) 11 (4) (2023)
Hager Salah, Al Shaimaa Ibrahim Rabie, Amira S A Said, Mohammad M AlAhmad, Ahmed Hassan Shaaban, Doaa Mahmoud Khalil, Raghda R S Hussein, Azza Khodary
COVID-19's Psychological Impact on Chronic Disease Patients Seeking Medical Care. Healthcare (Basel, Switzerland) 11 (6) (2023)
Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, Roquyya Gul, Muhammad Irfan, Muhammad Naveed, Munir Ahmad Bhinder, Muhammad Usman Ghani, Nadia Hussain, Amira S A Said, Amal H I Al Haddad, Mahjabeen Saleem
Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches. Vaccines 11 (1) (2023)
Hager Salah, Israa Sinan, Omar Alsamani, Lamyaa Samir Abdelghani, May Hassan ElLithy, Nazar Bukamal, Huda Jawad, Raghda R S Hussein, Marwa O Elgendy, Al Shaimaa Ibrahim Rabie, Doaa Mahmoud Khalil, Amira S A Said, Mohammad M AlAhmad, Azza Khodary
COVID-19 Booster Doses: A Multi-Center Study Reflecting Healthcare Providers' Perceptions. Vaccines 11 (6) (2023)
Moustafa Aldaly, Azza Hussien, Inas Mohsen El-Nadi, Nabila Ibrahim Laz, Amira S A Said, Mohammad M AlAhmad, Raghda R S Hussein, Al Shaimaa Ibrahim Rabie, Ahmed Hassan Shaaban
A Comparison of 3D Conformal and Deep Inspiratory Breath Holding vs. 4D-CT Intensity-Modulated Radiation Therapy for Patients with Left Breast Cancer. Cancers 15 (24) (2023)
Hager Salah, Al Shaimaa Ibrahim Rabie, Amira S A Said, Mohammad M AlAhmad, Ahmed Hassan Shaaban, Doaa Mahmoud Khalil, Raghda R S Hussein, Azza Khodary
COVID-19's Psychological Impact on Chronic Disease Patients Seeking Medical Care. Healthcare (Basel, Switzerland) 11 (6) (2023)
Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, Roquyya Gul, Muhammad Irfan, Muhammad Naveed, Munir Ahmad Bhinder, Muhammad Usman Ghani, Nadia Hussain, Amira S A Said, Amal H I Al Haddad, Mahjabeen Saleem
Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches. Vaccines 11 (1) (2023)
Al Shaimaa Ibrahim Rabie, Hager Salah, Amira S A Said, Ahmed Hassan Shaaban, Lamya Mohamed Abdou, Doaa Mahmoud Khalil, Zelal Kharaba, Hala Afifi, Mahmoud R Sofy, Eman M I Youssef, Eman S M Bayoumy, Raghda R S Hussein
Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection. Healthcare (Basel, Switzerland) 11 (4) (2023)
Hager Salah, Israa Sinan, Omar Alsamani, Lamyaa Samir Abdelghani, May Hassan ElLithy, Nazar Bukamal, Huda Jawad, Raghda R S Hussein, Marwa O Elgendy, Al Shaimaa Ibrahim Rabie, Doaa Mahmoud Khalil, Amira S A Said, Mohammad M AlAhmad, Azza Khodary
COVID-19 Booster Doses: A Multi-Center Study Reflecting Healthcare Providers' Perceptions. Vaccines 11 (6) (2023)
Al Shaimaa Ibrahim Rabie, Hager Salah, Amira S A Said, Ahmed Hassan Shaaban, Lamya Mohamed Abdou, Doaa Mahmoud Khalil, Zelal Kharaba, Hala Afifi, Mahmoud R Sofy, Eman M I Youssef, Eman S M Bayoumy, Raghda R S Hussein
Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection. Healthcare (Basel, Switzerland) 11 (4) (2023)
Heba F Salem, Marwa Mohamed Abd El-Maboud, Amira S A Said, Mohamed Nabil Salem, Dina Sabry, Nadia Hussain, Omnia A M Abd El-Ghafar, Raghda R S Hussein
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Heba F Salem, Marwa Mohamed Abd El-Maboud, Amira S A Said, Mohamed Nabil Salem, Dina Sabry, Nadia Hussain, Omnia A M Abd El-Ghafar, Raghda R S Hussein
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Heba F Salem, Marwa Mohamed Abd El-Maboud, Amira S A Said, Mohamed Nabil Salem, Dina Sabry, Nadia Hussain, Omnia A M Abd El-Ghafar, Raghda R S Hussein
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Heba F Salem, Marwa Mohamed Abd El-Maboud, Amira S A Said, Mohamed Nabil Salem, Dina Sabry, Nadia Hussain, Omnia A M Abd El-Ghafar, Raghda R S Hussein
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Heba F Salem, Marwa Mohamed Abd El-Maboud, Amira S A Said, Mohamed Nabil Salem, Dina Sabry, Nadia Hussain, Omnia A M Abd El-Ghafar, Raghda R S Hussein
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)